Regional health body weighs whether America keeps its measles-free standing

A PAHO committee meets from Nov. 11 to rule on U.S. measles elimination status; STAT's read is that the U.S. is likely to lose it.

A four-day meeting of a committee of the Pan American Health Organization, a regional arm of the World Health Organization, begins on Nov. 11, 2026. At its close, the committee is due to announce whether the United States has kept its measles elimination status. STAT's newsletter says all signs point to the U.S. losing it. That is the newsletter's own reading, not an official finding, and the ruling has yet to be announced.

The process runs on data. A U.S. committee analyzes the national numbers and sends a report to the PAHO committee. The chair of that U.S. committee wrote an essay in August describing what the process looks for. The backdrop is a sharp rise in U.S. measles cases over the last few years, and at least eight measles deaths reported in 2026. In January, Ralph Abraham, then a CDC official, said losing elimination status would be the cost of doing business.

Why it matters for abundance: elimination status is a measure of how reliably a country protects its people from a preventable disease. Vaccines for measles are cheap and effective, so keeping the disease out is one of the lowest-cost health gains a society can hold. Losing the status would mean that gain is being given back. That would raise future costs in outbreak response, hospital care and lives, and it would show that access to a basic protection can erode even in a wealthy country.

What to watch: the committee's announcement, and what it cites as the reasons. The newsletter also flagged other U.S. health policy items, including a proposal to cut 6.3 million more families from SNAP, but the measles ruling is the one still pending.

Source: STAT